NTRB
NASDAQ · Pharmaceuticals
Nutriband Inc
$6.90
+0.14 (+2.07%)
Open$6.76
Previous Close$6.76
Day High$6.94
Day Low$6.56
52W High$8.63
52W Low$2.80
Volume—
Avg Volume92.9K
Market Cap92.99M
P/E Ratio—
EPS$-0.58
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+400.1% upside
Current
$6.90
$6.90
Target
$34.51
$34.51
$26.32
$34.51 avg
$56.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.23M | 2.24M | 21.69M |
| Net Income | -8,993,791 | -8,150,651 | 2.61M |
| Profit Margin | -404.1% | -383.9% | 12.0% |
| EBITDA | -8,878,030 | -8,492,728 | 4.63M |
| Free Cash Flow | — | — | 2.95M |
| Rev Growth | -0.7% | -0.7% | +19.5% |
| Debt/Equity | 0.02 | 0.02 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,148.51 | -1.85% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $267.76 | -0.53% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $147.66 | -2.15% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.05 | +0.43% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.77 | -1.50% | 11.5 | 30.15B |